Pharmacogenomic Knowledge Graph Augmentation for Graph Neural Network-Based Drug-Drug Interaction Prediction

• URL: http://arxiv.org/abs/2606.07698v1
• Date: Fri, 05 Jun 2026 07:47:32 GMT
• Title: Pharmacogenomic Knowledge Graph Augmentation for Graph Neural Network-Based Drug-Drug Interaction Prediction
• Abstract summary: Graph neural networks (GNNs) applied to drug-drug interaction (DDI) prediction rely exclusively on molecular structure encoded as SMILES-derived graphs.<n>The present study investigates whether pharmacogenomic prior knowledge partially closes this gap.<n>Experiments are conducted under both pair-level and drug-level data splits to quantify generalization to unseen drugs.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Graph neural networks (GNNs) applied to drug-drug interaction (DDI) prediction rely exclusively on molecular structure encoded as SMILES-derived graphs. Prior work in this series demonstrated that model performance is bounded by the structural information content of training labels -- an Information Ceiling -- that architectural refinements alone cannot overcome. The present study investigates whether pharmacogenomic prior knowledge from the PharmGKB database partially closes this ceiling by providing metabolic pathway context that is independent of, and complementary to, molecular structure. Cytochrome P450 (CYP) enzyme substrate, inhibitor, and inducer annotations for four clinically relevant isoforms (CYP2D6, CYP3A4, CYP2C19, CYP2C9) are extracted and incorporated as a 12-dimensional feature vector concatenated to the molecular embedding prior to interaction prediction. Experiments are conducted under both pair-level and drug-level data splits to quantify generalization to unseen drugs. Results indicate that knowledge graph (KG) augmentation substantially improves DDI type classification under pair-level split conditions (F1-macro: 0.532 vs. 0.241 baseline), while binary interaction detection and drug-level generalization remain bounded by the Information Ceiling (AUC inflation: 0.224 vs. 0.250 baseline). Mechanistic validation on strictly held-out compounds confirms that augmentation preferentially improves CYP2C9-mediated interaction prediction, with probabilities increasing from 0.033-0.117 (baseline) to 0.560-0.586 (KG-augmented). An extension to single-molecule toxicity prediction on the Tox21 benchmark confirms that the effect is contingent on pharmacogenomic annotation coverage. These findings motivate the multimodal framework proposed for the subsequent study in this series.

Related papers

• What Molecular Structure Cannot Tell Us: A Taxonomy of Explainability Gaps in GNN-Based Drug Toxicity Prediction [0.0]
  This study introduces an operational taxonomy of the structural information limits that prevent structure-based toxicity prediction.<n>A systematic case study using acetylsalicylic acid (ASA, Aspirin) serves as model compound.<n>Results indicate that molecular structure explains approximately 45% (5/11) of known ASA adverse effects.
  arXiv  Detail & Related papers  (2026-05-25T07:51:15Z)
• Pharmacology Knowledge Graphs: Do We Need Chemical Structure for Drug Repurposing? [0.0]
  We constructed a pharmacology knowledge graph from ChEMBL 36 comprising 5,348 entities including 3,127 drugs, 1,156 proteins, and 1,065 indications.<n>We benchmarked five knowledge graph embedding models and a standard graph neural network with 3.44 million parameters that incorporates drug chemical structure using a graph attention encoder and ESM-2 protein embeddings.<n>Removing the graph attention based drug structure encoder and retaining only topological embeddings combined with ESM-2 protein features improved drug protein PR-AUC from 0.5631 to 0.5785 while reducing VRAM usage from GB to 353 MB.
  arXiv  Detail & Related papers  (2026-03-02T07:07:32Z)
• Composable Score-based Graph Diffusion Model for Multi-Conditional Molecular Generation [85.58520120011269]
  We propose Composable Score-based Graph Diffusion model (CSGD), which extends score matching to discrete graphs via concrete scores.<n>We show that CSGD achieves state-of-the-art performance with a 15.3% average improvement in controllability over prior methods.<n>Our findings highlight the practical advantages of score-based modeling for discrete graph generation and its capacity for flexible, multi-property molecular design.
  arXiv  Detail & Related papers  (2025-09-11T13:37:56Z)
• Structure-Aware Compound-Protein Affinity Prediction via Graph Neural Network with Group Lasso Regularization [11.87029706744257]
  We propose a framework by implementing graph neural networks (GNNs) to predict compound-protein affinity.<n>We train GNNs with structure-aware loss functions using group lasso and sparse group lasso coloring regularizations.<n>Our approach improved property prediction by integrating common and uncommon node information with sparse group lasso.
  arXiv  Detail & Related papers  (2025-07-04T06:12:18Z)
• Regressor-free Molecule Generation to Support Drug Response Prediction [83.25894107956735]
  Conditional generation based on the target IC50 score can obtain a more effective sampling space. Regressor-free guidance combines a diffusion model's score estimation with a regression controller model's gradient based on number labels.
  arXiv  Detail & Related papers  (2024-05-23T13:22:17Z)
• Learning to Denoise Biomedical Knowledge Graph for Robust Molecular Interaction Prediction [50.7901190642594]
  We propose BioKDN (Biomedical Knowledge Graph Denoising Network) for robust molecular interaction prediction. BioKDN refines the reliable structure of local subgraphs by denoising noisy links in a learnable manner. It maintains consistent and robust semantics by smoothing relations around the target interaction.
  arXiv  Detail & Related papers  (2023-12-09T07:08:00Z)
• Bi-level Contrastive Learning for Knowledge-Enhanced Molecule Representations [68.32093648671496]
  We introduce GODE, which accounts for the dual-level structure inherent in molecules.<n> Molecules possess an intrinsic graph structure and simultaneously function as nodes within a broader molecular knowledge graph.<n>By pre-training two GNNs on different graph structures, GODE effectively fuses molecular structures with their corresponding knowledge graph substructures.
  arXiv  Detail & Related papers  (2023-06-02T15:49:45Z)
• Associative Learning Mechanism for Drug-Target Interaction Prediction [6.107658437700639]
  Drug-target affinity (DTA) represents the strength of drug-target interaction (DTI) Traditional methods lack the interpretability of the DTA prediction process. This paper proposes a DTA prediction method with interactive learning and an autoencoder mechanism.
  arXiv  Detail & Related papers  (2022-05-24T14:25:28Z)
• Hierarchical Graph Representation Learning for the Prediction of Drug-Target Binding Affinity [7.023929372010717]
  We propose a novel hierarchical graph representation learning model for the drug-target binding affinity prediction, namely HGRL-DTA. In this paper, we adopt a message broadcasting mechanism to integrate the hierarchical representations learned from the global-level affinity graph and the local-level molecular graph. Besides, we design a similarity-based embedding map to solve the cold start problem of inferring representations for unseen drugs and targets.
  arXiv  Detail & Related papers  (2022-03-22T04:50:16Z)
• Improved Drug-target Interaction Prediction with Intermolecular Graph Transformer [98.8319016075089]
  We propose a novel approach to model intermolecular information with a three-way Transformer-based architecture. Intermolecular Graph Transformer (IGT) outperforms state-of-the-art approaches by 9.1% and 20.5% over the second best for binding activity and binding pose prediction respectively. IGT exhibits promising drug screening ability against SARS-CoV-2 by identifying 83.1% active drugs that have been validated by wet-lab experiments with near-native predicted binding poses.
  arXiv  Detail & Related papers  (2021-10-14T13:28:02Z)
• MolTrans: Molecular Interaction Transformer for Drug Target Interaction Prediction [68.5766865583049]
  Drug target interaction (DTI) prediction is a foundational task for in silico drug discovery. Recent years have witnessed promising progress for deep learning in DTI predictions. We propose a Molecular Interaction Transformer (TransMol) to address these limitations.
  arXiv  Detail & Related papers  (2020-04-23T18:56:04Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.